Astec Lifesciences
- Advice
- Hold
Astec Lifesciences Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Astec Lifesciences
Start SIPAstec Lifesciences Investment Rating
-
Master Rating:
-
Astec Lifesciences has an operating revenue of Rs. 773.18 Cr. on a trailing 12-month basis. An annual revenue growth of 22% is outstanding, Pre-tax margin of 18% is great, ROE of 22% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 78 which is a FAIR score but needs to improve its earnings, a RS Rating of 24 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 91 indicates it belongs to a poor industry group of Chemicals-Agricultural and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 117 | 200 | 184 | 272 |
| Operating Expenses Qtr Cr | 105 | 166 | 159 | 207 |
| Operating Profit Qtr Cr | 12 | 33 | 25 | 65 |
| Depreciation Qtr Cr | 9 | 8 | 9 | 11 |
| Interest Qtr Cr | 6 | 5 | 4 | 3 |
| Tax Qtr Cr | 0 | 6 | 4 | 15 |
| Net Profit Qtr Cr | 1 | 18 | 11 | 43 |
Astec Lifesciences Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 9
- Bearish Moving Average
- ___
- 7
- 20 Day
- 1286.42
- 50 Day
- 1403.31
- 100 Day
- 1552.77
- 200 Day
- 1655.95
- 20 Day
- 1287.39
- 50 Day
- 1396.99
- 100 Day
- 1639.34
- 200 Day
- 1790.36
Astec Lifesciences Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 1383.2 |
| Second Resistance | 1456 |
| Third Resistance | 1601.6 |
| RSI | 56.16 |
| MFI | 89.32 |
| MACD Single Line | -61.37 |
| MACD | -46.57 |
| Support | |
|---|---|
| First Resistance | 1164.8 |
| Second Resistance | 1019.2 |
| Third Resistance | 946.4 |
Astec Lifesciences Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 854,319 | 6,151,097 | 7.2 |
| Week | 315,232 | 3,587,334 | 11.38 |
| 1 Month | 73,792 | 1,306,855 | 17.71 |
| 6 Month | 38,296 | 1,370,631 | 35.79 |
Astec Lifesciences Result Highlights
Astec Lifesciences Synopsis
NSE-Chemicals-Agricultural
Astec Lifesciences L is involved in the business activities of Manufacture of insecticides, rodenticides, fungicides, herbicides. Company’s Total Operating Revenue is Rs. 676.57 Cr. and Equity Capital is Rs. 19.60 Cr. for the Year ended 31/03/2022. Astec Lifesciences Ltd. is a Public Limited Listed company incorporated on 25/01/1994 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1994PLC076236 and registration number is 076236.| Market Cap | 2,715 |
| Sales | 773 |
| Shares in Float | 0.65 |
| No of funds | 55 |
| Yield | 0.11 |
| Book Value | 6.85 |
| U/D Vol ratio | 0.4 |
| LTDebt / Equity | 13 |
| Alpha | -0.07 |
| Beta | 0.82 |
Astec Lifesciences
| Owner Name | Dec-22 | Sep-22 | Jun-22 |
|---|---|---|---|
| Promoters | 66.77% | 66.77% | 65.29% |
| Mutual Funds | 8.45% | 8.71% | 7.98% |
| Insurance Companies | 2.26% | ||
| Foreign Portfolio Investors | 2.19% | 1.53% | 0.48% |
| Financial Institutions/ Banks | |||
| Individual Investors | 17.86% | 18.02% | 18.26% |
| Others | 4.73% | 4.97% | 5.73% |
Astec Lifesciences Management
| Name | Designation |
|---|---|
| Mr. Nadir B Godrej | Chairman |
| Mr. Ashok V Hiremath | Non Executive Director |
| Mr. Balram Singh Yadav | Non Executive Director |
| Mr. Anurag Roy | WholeTime Director & CEO |
| Dr. Brahma Nand Vyas | Ind. Non-Executive Director |
| Mr. Vijay Kashinath Khot | Ind. Non-Executive Director |
| Mr. R R Govindan | Ind. Non-Executive Director |
| Mr. Nandkumar Dhekne | Ind. Non-Executive Director |
| Ms. Anjali Gupte | Independent Director |
| Mr. Burjis Nadir Godrej | Non Exe.Non Ind.Director |
Astec Lifesciences Forecast
Price Estimates
Astec Lifesciences FAQs
What is Share Price of Astec Lifesciences ?
Astec Lifesciences share price is ₹1385 As on 02 April, 2023 | 05:36
What is the Market Cap of Astec Lifesciences ?
The Market Cap of Astec Lifesciences is ₹2715.4 Cr As on 02 April, 2023 | 05:36
What is the P/E ratio of Astec Lifesciences ?
The P/E ratio of Astec Lifesciences is 36.9 As on 02 April, 2023 | 05:36
What is the PB ratio of Astec Lifesciences ?
The PB ratio of Astec Lifesciences is 6.8 As on 02 April, 2023 | 05:36